Galmed Pharma (GLMD) Tops Q1 EPS by 10c
Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.15), $0.10 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.
Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of ($0.15), $0.10 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.